Catalysts for Zydus Therapeutics Inc
52 tracked
Sep 17, 2024
approval
BOSENTAN โ FDA approval
Zydus Therapeutics Inc
โ
May 30, 2024
approval
BOSENTAN โ FDA approval
Zydus Therapeutics Inc
โ
Dec 15, 2023
approval
FENTANYL-100 (FENTANYL) โ FDA approval
Zydus Therapeutics Inc
โ
Dec 15, 2023
approval
FENTANYL-100 (FENTANYL) โ FDA approval
Zydus Therapeutics Inc
โ
Aug 29, 2023
approval
ISOTRETINOIN โ FDA approval
Zydus Therapeutics Inc
โ
Mar 30, 2023
approval
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE (LINAGLIPTIN) โ FDA approval
Zydus Therapeutics Inc
โ
Mar 27, 2023
approval
HALOPERIDOL DECANOATE โ FDA approval
Zydus Therapeutics Inc
โ
Mar 9, 2023
approval
OLANZAPINE โ FDA approval
Zydus Therapeutics Inc
โ
Jan 24, 2023
approval
FENTANYL-100 (FENTANYL) โ FDA approval
Zydus Therapeutics Inc
โ
Jun 17, 2022
approval
TRANEXAMIC ACID โ FDA approval
Zydus Therapeutics Inc
โ
May 25, 2022
approval
TIZANIDINE HYDROCHLORIDE โ FDA approval
Zydus Therapeutics Inc
โ
Apr 29, 2022
approval
BOSENTAN โ FDA approval
Zydus Therapeutics Inc
โ
Mar 10, 2021
approval
LAMOTRIGINE โ FDA approval
Zydus Therapeutics Inc
โ
Apr 1, 2020
approval
LAMOTRIGINE โ FDA approval
Zydus Therapeutics Inc
โ
Nov 1, 2019
approval
BOSENTAN โ FDA approval
Zydus Therapeutics Inc
โ
Oct 22, 2019
approval
HALOPERIDOL DECANOATE โ FDA approval
Zydus Therapeutics Inc
โ
Apr 26, 2019
approval
BOSENTAN โ FDA approval
Zydus Therapeutics Inc
โ
May 14, 2018
approval
TRANEXAMIC ACID โ FDA approval
Zydus Therapeutics Inc
โ
Sep 28, 2017
approval
DOXYCYCLINE โ FDA approval
Zydus Therapeutics Inc
โ
Aug 8, 2017
approval
DILTIAZEM HYDROCHLORIDE โ FDA approval
Zydus Therapeutics Inc
โ
Jul 17, 2017
approval
TRANEXAMIC ACID โ FDA approval
Zydus Therapeutics Inc
โ
Mar 3, 2017
approval
TIZANIDINE HYDROCHLORIDE โ FDA approval
Zydus Therapeutics Inc
โ